Galapagos NV
GLPG
#4542
Rank
โ‚น197.94 B
Marketcap
โ‚น2,998
Share price
-1.60%
Change (1 day)
35.00%
Change (1 year)

EPS for Galapagos NV (GLPG)

EPS in 2025 (TTM): -โ‚น34.67

According to Galapagos NV's latest financial reports the company's current EPS (TTM) is -โ‚น31.76. In 2024 the company made an earnings per share (EPS) of โ‚น109.15 a decrease over its 2023 EPS that were of โ‚น332.33.

EPS history for Galapagos NV from 2004 to 2025

Annual EPS

Year EPS Change
2025 (TTM)-โ‚น34.67-131.76%
2024โ‚น109.15-67.16%
2023โ‚น332.33-199.64%
2022-โ‚น333.5299.03%
2021-โ‚น167.58-68.98%
2020-โ‚น540.25-298.06%
2019โ‚น272.77-554.64%
2018-โ‚น60.00-77.18%
2017-โ‚น262.94-326.21%
2016โ‚น116.24-134.19%
2015-โ‚น339.96-371.34%
2014โ‚น125.29-445.98%
2013-โ‚น36.2132.88%
2012-โ‚น27.25-82.07%
2011-โ‚น152.03-817.9%
2010โ‚น21.1812.73%
2009โ‚น18.78-120.79%
2008-โ‚น90.34-37.67%
2007-โ‚น144.9539.64%
2006-โ‚น103.8028.17%
2005-โ‚น80.996.25%
2004-โ‚น76.22

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
โ‚น1,043-3,384.24%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
โ‚น351.10-1,205.50%๐Ÿ‡บ๐Ÿ‡ธ USA
AbbVie
ABBV
โ‚น224.00-805.31%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
โ‚น193.41-708.98%๐Ÿ‡ซ๐Ÿ‡ท France
Merck
MRK
โ‚น684.29-2,254.65%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
โ‚น501.04-1,677.63%๐Ÿ‡ฌ๐Ÿ‡ง UK
GSK plc
GSK
โ‚น352.88-1,211.13%๐Ÿ‡ฌ๐Ÿ‡ง UK
Fortress Biotech
FBIO
-โ‚น57.13 79.88%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
โ‚น116.13-465.66%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel